DENDROCYTE BIOTECH PTY LTD has a total of 15 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SYMPHOGEN A, IMCHECK THERAPEUTICS SAS and I MAB BIOPHARMA US LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | United States | 3 | |
#4 | Canada | 2 | |
#5 | Australia | 1 | |
#6 | China | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hart Derek Nigel John | 9 |
#2 | Clark Georgina Jane | 7 |
#3 | Gasiorowski Robin | 4 |
#4 | Marks James D | 3 |
#5 | Munro Trent Phillip | 3 |
#6 | Casey Joanne L | 3 |
#7 | Mahler Stephen Michael | 3 |
#8 | Jones Martina Louise | 3 |
#9 | Coley Andrew M | 3 |
#10 | Seldon Therese Ann | 3 |
Publication | Filing date | Title |
---|---|---|
WO2021016668A1 | Immunoconjugate | |
AU2017364473A1 | Anti-cd300f antibody and uses thereof | |
EP3209695A1 | Cd83 binding proteins and uses thereof |